Mirae Asset Global ETFs Holdings’s BeOne Medicines Ltd ONC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Buy	6,365 +502	+9%	+$148K	﹤0.01%	1301
2026 Q1	$1.74M	Buy	5,863 +916	+19%	+$297K	﹤0.01%	1242
2025 Q4	$1.5M	Buy	4,947 +78	+2%	+$25.5K	﹤0.01%	1301
2025 Q3	$1.66M	Buy	+4,869	New	+$1.48M	﹤0.01%	1231
2025 Q2	–	Sell	-4,760	Closed	-$1.3M	–	3296
2025 Q1	$1.3M	Sell	4,760 -83	-2%	-$19.4K	﹤0.01%	1366
2024 Q4	$895K	Sell	4,843 -157	-3%	-$32.1K	﹤0.01%	1607
2024 Q3	$1.12M	Buy	5,000 +79	+2%	+$14.2K	﹤0.01%	1475
2024 Q2	$702K	Buy	+4,921	New	+$758K	﹤0.01%	1646

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ONC Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its BeOne Medicines Ltd (ONC) stake by 8.6% in Q2 2026, buying an estimated $148K and bringing the position to 6,365 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1301.

Mirae Asset Global ETFs Holdings first reported a position in ONC in Q2 2024 and has held it in 8 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Mirae Asset Global ETFs Holdings held 6,365 shares of BeOne Medicines Ltd worth $1.81M as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 502 BeOne Medicines Ltd shares in Q2 2026, an estimated $148K.
BeOne Medicines Ltd made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1301 holding.
Mirae Asset Global ETFs Holdings first reported a position in BeOne Medicines Ltd in Q2 2024 and has held it in 8 quarters since.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.